Found 16 matching trials
Tshireletso: Safety, Efficacy and Feasibility of Cabotegravir-LA PrEP in a Breastfeeding Population in Botswana PHASE4 The goal of this this hybrid safety/implementation study is to evaluate whe...
Show More Status
Active Not Recruiting
Location
Beth Israel Deaconess Medical Center
Learn More & Join Trial
Cisgender Female Patients Who Start on Long Acting Cabotegravir for PrEP N/A Oral PrEP regimens (FTC/TDF have been the mainstay of HIV prevention howeve...
Show More Status
Active Not Recruiting
Location
Midway Specialty Care Center
Learn More & Join Trial
Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France. PHASE3 The purpose of this study is to evaluate if offering long-acting injectable...
Show More Location
Hôpital Hôtel Dieu
Learn More & Join Trial
A Pharmacist-run PrEP Program for Women N/A The primary objective of this study is to evaluate uptake and retention of ...
Show More Location
Orlando Immunology Center
Learn More & Join Trial
Oregon PrEP at Home Study N/A This demonstration study will evaluate the real-world implementation of lon...
Show More Location
Oregon Health & Science University
Learn More & Join Trial
A Study Evaluating Implementation Strategies for the Delivery of Cabotegravir in Low and High-Volume PrEP Site in the United States PHASE4 This is a two-arm study evaluating the impact of two implementation strateg...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study Evaluating Implementation Strategies for the Delivery of APRETUDE for Black cis-and Transgender Women in United States EHE Territories PHASE4 The purpose of the study is to evaluate the appropriateness, adoption, feas...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs PHASE4 The goal of this study is to determine the feasibility and impact of delive...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Parrying the Pitfalls of PrEP: Project PEACH PHASE4 The study is a prospective cohort of young MSM who are followed for 2 years...
Show More Location
PRISM Research Center
Learn More & Join Trial
Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus) PHASE3 The purpose of this study is long-term evaluation of long-acting injectable...
Show More Status
Active Not Recruiting
Location
GSK Investigational Site
Learn More & Join Trial